5% stakes
Orbimed Advisors
Institution
- 5% stake reports
- 68
- 5% stake stocks
- 36
- Latest report
- 26/09/25
5% stake reports
| Stock | ||
|---|---|---|
| Electra Therapeutics ETRA09/25 | 11%6,885,170 sh | First report |
| Braveheart Bio BRVE09/10 | 13.5%12,175,159 sh | −3.7pp |
| Braveheart Bio BRVE08/18 | 17.2%12,175,159 sh | First report |
| BlossomHill Therapeutics BLSM08/18 | 8.9%2,714,279 sh | First report |
| Whitehawk Therapeutics WHWK08/14 | 7.3%3,934,296 sh | −1.6pp |
| Vistagen Therapeutics VTGN08/14 | 0%0 sh | −4.2pp |
| Spruce Biosciences SPRB08/14 | 4.8%132,200 sh | First report |
| NeuroPace NPCE08/14 | 4.4%1,505,125 sh | −1.8pp |
| Lexeo Therapeutics LXEO08/14 | 4.1%3,203,050 sh | First report |
| Immunic IMUX08/14 | 5.3%756,860 sh | First report |
| MBX Biosciences MBX08/10 | 6.4%3,074,853 sh | −1.3pp |
| Yarrow Bioscience YARW08/05 | 9.97%266,306 sh | First report |
| Scribe Therapeutics SCTX07/29 | 7.2%1,348,825 sh | First report |
| Q32 Bio QTTB07/20 | 13.9%4,127,987 sh | −3.5pp |
| Enliven Therapeutics ELVN06/24 | 9.5%6,774,507 sh | −1.4pp |
| Enliven Therapeutics ELVN06/17 | 10.93%7,634,630 sh | −2.5pp |
| Shattuck Labs STTK06/15 | 9.99%9,021,127 sh | +0.0pp |
| Q32 Bio QTTB06/01 | 17.4%4,127,987 sh | +4.1pp |
| Xilio Therapeutics XLO05/15 | 9.99%642,000 sh | First report |
| NeuroPace NPCE05/15 | 6.2%2,096,527 sh | −1.8pp |
